vs
PROTHENA CORP PUBLIC LTD CO（PRTA）与ReNew Energy Global plc（RNW）财务数据对比。点击上方公司名可切换其他公司
PROTHENA CORP PUBLIC LTD CO的季度营收约是ReNew Energy Global plc的1.2倍（$21.0K vs $17.0K）
Prothena Corporation plc是一家处于临床后期阶段的生物技术企业，专注于开发和商业化针对神经退行性疾病、罕见病及免疫相关病症的创新抗体疗法，核心管线覆盖淀粉样变性、帕金森病、阿尔茨海默病等领域，核心市场包括北美、欧洲及亚太地区。
ReNew Energy Global plc是印度可再生能源企业，总部位于古尔冈，是首家在纳斯达克上市的印度可再生能源公司，在印度10个邦运营超过150个项目，是印度可再生能源领域的代表性企业。
PRTA vs RNW — 直观对比
营收规模更大
PRTA
是对方的1.2倍
$17.0K
损益表 — Q4 FY2025 vs Q2 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $21.0K | $17.0K |
| 净利润 | — | — |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | — | — |
| 营收同比 | -99.0% | — |
| 净利润同比 | 62.7% | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRTARNW
| Q4 25 | $21.0K | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $2.8M | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $970.0K | — | ||
| Q2 24 | $132.0M | — | ||
| Q1 24 | $50.0K | — |
净利润PRTARNW
| Q4 25 | — | — | ||
| Q3 25 | $-36.5M | — | ||
| Q2 25 | $-125.8M | — | ||
| Q1 25 | $-60.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-59.0M | — | ||
| Q2 24 | $66.9M | — | ||
| Q1 24 | $-72.2M | — |
营业利润率PRTARNW
| Q4 25 | — | — | ||
| Q3 25 | -1666.3% | — | ||
| Q2 25 | -1914.4% | — | ||
| Q1 25 | -2319.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6857.0% | — | ||
| Q2 24 | 44.2% | — | ||
| Q1 24 | -163056.0% | — |
净利率PRTARNW
| Q4 25 | — | — | ||
| Q3 25 | -1513.1% | — | ||
| Q2 25 | -2845.4% | — | ||
| Q1 25 | -2128.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6082.6% | — | ||
| Q2 24 | 50.7% | — | ||
| Q1 24 | -144478.0% | — |
每股收益（稀释后）PRTARNW
| Q4 25 | — | — | ||
| Q3 25 | $-0.68 | — | ||
| Q2 25 | $-2.34 | — | ||
| Q1 25 | $-1.12 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.10 | — | ||
| Q2 24 | $1.22 | — | ||
| Q1 24 | $-1.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $280.5M | — |
| 总资产 | $326.8M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRTARNW
| Q4 25 | $307.5M | — | ||
| Q3 25 | $330.8M | — | ||
| Q2 25 | $371.4M | — | ||
| Q1 25 | $417.9M | — | ||
| Q4 24 | $471.4M | — | ||
| Q3 24 | $519.3M | — | ||
| Q2 24 | $564.1M | — | ||
| Q1 24 | $546.5M | — |
股东权益PRTARNW
| Q4 25 | $280.5M | — | ||
| Q3 25 | $295.0M | — | ||
| Q2 25 | $324.3M | — | ||
| Q1 25 | $437.7M | — | ||
| Q4 24 | $486.9M | — | ||
| Q3 24 | $534.4M | — | ||
| Q2 24 | $581.9M | — | ||
| Q1 24 | $502.4M | — |
总资产PRTARNW
| Q4 25 | $326.8M | — | ||
| Q3 25 | $352.6M | — | ||
| Q2 25 | $399.1M | — | ||
| Q1 25 | $495.3M | — | ||
| Q4 24 | $547.1M | — | ||
| Q3 24 | $595.3M | — | ||
| Q2 24 | $645.6M | — | ||
| Q1 24 | $623.2M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-163.6M | $4.4K |
| 自由现金流经营现金流 - 资本支出 | — | $-23.6K |
| 自由现金流率自由现金流/营收 | — | -139.0% |
| 资本支出强度资本支出/营收 | — | 164.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PRTARNW
| Q4 25 | $-163.6M | — | ||
| Q3 25 | $-40.6M | — | ||
| Q2 25 | $-46.3M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $-150.1M | — | ||
| Q3 24 | $-45.2M | — | ||
| Q2 24 | $16.0M | — | ||
| Q1 24 | $-73.1M | — |
现金转化率PRTARNW
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
